cardiovascular system
• left ventricle wall shows myocardial degeneration
• treatment with EUK-8, a superoxide dismutase and catalase mimetic, diminishes myocardial degeneration
|
• left ventricle wall shows myocyte disarray
• EUK-8 treated mice show diminished myocyte disarray
|
• progressively increasing heart-to-body weight ratio
• treatment with EUK-8, a superoxide dismutase and catalase mimetic, decreases heart weight
|
• diffuse fibrotic scars surrounding myocardial cells
• EUK-8 treated mice show diminished fibrosis
|
• heart dilatation
|
• increase in left ventricular end-diastolic internal dimension (LVIDd)
• EUK-8 treatment for 4 weeks decreases LVIDd
|
• increase in left ventricular end-diastolic internal dimension (LVIDd)
• EUK-8 treatment for 4 weeks decreases LVIDd
|
growth/size/body
• progressively increasing heart-to-body weight ratio
• treatment with EUK-8, a superoxide dismutase and catalase mimetic, decreases heart weight
|
cellular
• diffuse fibrotic scars surrounding myocardial cells
• EUK-8 treated mice show diminished fibrosis
|
• heart tissue exhibits oxidative DNA damage
• EUK-8 treatment attenuates oxidative DNA damage in heart tissue
|
homeostasis/metabolism
• telomerase activity is decreased in heart tissues, however telomere length is normal
• EUK-8 treatment restores normal telomerase activity
|
muscle
• left ventricle wall shows myocardial degeneration
• treatment with EUK-8, a superoxide dismutase and catalase mimetic, diminishes myocardial degeneration
|
• left ventricle wall shows myocyte disarray
• EUK-8 treated mice show diminished myocyte disarray
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
congestive heart failure | DOID:6000 | J:171017 | ||
dilated cardiomyopathy | DOID:12930 |
OMIM:PS115200 |
J:171017 |